Senator Lacson: “It’s quite obvious na yung House, allies ng Palasyo”
On Tuesday, Senator Panfilo Lacson said that there has yet to be solid evidence that would link President Rodrigo Duterte to the government’s deals with Pharmally Pharmaceutical Corporation.
This, as the senator questioned a House panel’s supposed effort to “protect” Malacañang.
In an interview on ABS-CBN News Channel, Lacson said that it’s “obvious” that the parallel investigation of the House of Representatives was only meant to “protect” the interest of Malacañang.
“It’s quite obvious na yung House, allies ng Palasyo. And it’s now doing everything it can to, not really divert the issue, but they’re even hitting the Senate’s investigation,” Lacson said.
Inquirer reported that the Senate and the House of Representatives were embarking on separate investigations into the use of pandemic response funds.
The Senate was particularly looking into the controversial multi-billion contracts awarded to Pharmally Pharmaceutical Corporation.
READ ALSO: Gordon Says Pharmally’s Mago May Become “Fugitive” If Remains Unreachable
Lacson said that the inter-parliamentary courtesy had been “thrown out the window” with some House lawmakers criticizing the investigation of the Senate.
“There’s no inter-parliamentary courtesy, [it’s] thrown out of the window. Napaka-obvious naman na yung parallel investigation ng House para lang protektahan yung interes ng Malacañang,” Lacson said.
The senator was puzzled by efforts to supposedly “protect” Malacañang when there has yet to be concrete evidence that could link the President to Pharmally’s deals with the government.
Nevertheless, the senator questioned President Duterte’s defense of some of the personalities linked to the controversial procurement.
Meanwhile, Lacson revealed that he and his running mate, Senate President Vicente Sotto III, will file their certificates of candidacy (COC) on October 6, 2021.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
